Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2146 | 4.76317308119 | 4.5054 | 4.905 | 4.2 | 108418 | 4.59840624 | CS |
| 4 | 0.6 | 14.5631067961 | 4.12 | 5.14 | 3.52 | 192061 | 4.28383911 | CS |
| 12 | -0.1 | -2.07468879668 | 4.82 | 5.15 | 3.52 | 181712 | 4.43580579 | CS |
| 26 | -2.39 | -33.6146272855 | 7.11 | 8.56 | 3.52 | 207341 | 5.89390686 | CS |
| 52 | -13.28 | -73.7777777778 | 18 | 18.5 | 3.52 | 333508 | 9.77177435 | CS |
| 156 | -8.08 | -63.125 | 12.8 | 29.8 | 3.52 | 645137 | 12.84902872 | CS |
| 260 | -75.48 | -94.114713217 | 80.2 | 269.8 | 3.52 | 1015138 | 49.8024679 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
